TCP
CYCN icon

Tyndall Capital Partners’s Cyclerion Therapeutics CYCN Stock Holding History

Tyndall Capital Partners’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-155,187
Closed -$452K – 1
2025
Q2 		$452K Sell
155,187
-9,590
-6% -$28.6K 100% 1
2025
Q1 		$412K Hold
164,777
– – 100% 1
2024
Q4 		$531K Hold
164,777
– – 100% 1
2024
Q3 		$427K Hold
164,777
– – 100% 1
2024
Q2 		$379K Hold
164,777
– – 100% 1
2024
Q1 		$527K Buy
164,777
+348
+0.2% +$1.11K 100% 1
2023
Q4 		$551K Buy
164,429
+16,717
+11% +$48.3K 100% 1
2023
Q3 		$505K Buy
+147,712
New +$533K 100% 1

Other funds holding CYCN

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $1.84B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return